Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 13, 2024

SELL
$0.41 - $0.86 $3,023 - $6,341
-7,374 Reduced 3.76%
188,924 $162,000
Q3 2023

Nov 13, 2023

BUY
$0.38 - $0.72 $38 - $73
102 Added 0.05%
196,298 $84,000
Q2 2023

Aug 11, 2023

SELL
$0.54 - $0.95 $33,747 - $59,371
-62,496 Reduced 24.16%
196,196 $113,000
Q1 2023

May 12, 2023

BUY
$0.9 - $1.34 $1,667 - $2,483
1,853 Added 0.72%
258,692 $248,000
Q4 2022

Feb 13, 2023

SELL
$0.85 - $16.65 $5,141 - $100,715
-6,049 Reduced 2.3%
256,839 $272,000
Q3 2022

Nov 14, 2022

SELL
$1.15 - $17.4 $2,480 - $37,531
-2,157 Reduced 0.81%
262,888 $278,000
Q2 2022

Aug 12, 2022

SELL
$1.19 - $2.0 $321 - $540
-270 Reduced 0.1%
265,045 $384,000
Q1 2022

May 12, 2022

SELL
$1.23 - $1.9 $11,146 - $17,217
-9,062 Reduced 3.3%
265,315 $472,000
Q4 2021

Feb 10, 2022

BUY
$1.64 - $2.83 $6,519 - $11,249
3,975 Added 1.47%
274,377 $510,000
Q3 2021

Nov 09, 2021

SELL
$2.7 - $3.59 $18,478 - $24,569
-6,844 Reduced 2.47%
270,402 $812,000
Q2 2021

Aug 11, 2021

BUY
$3.21 - $4.06 $889,959 - $1.13 Million
277,246 New
277,246 $1.02 Million

Others Institutions Holding MBRX

About Moleculin Biotech, Inc.


  • Ticker MBRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 28,606,700
  • Market Cap $48.6M
  • Description
  • Moleculin Biotech, Inc., a clinical-stage pharmaceutical company, focuses on the development of drug candidates for the treatment of highly resistant tumors and viruses. Its lead drug candidate is Annamycin that is in Phase 1/2 studies for the treatment of relapsed or refractory acute myeloid leukemia (AML) and cancers metastasized to the lungs....
More about MBRX
Track This Portfolio

Track Black Rock Inc. Portfolio

Follow Black Rock Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.